Arcutis Biotherapeutics, Inc. ARQT FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s FX effect on cash?
- Arcutis Biotherapeutics, Inc. (ARQT) reported FX effect on cash of -$119K in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s FX effect on cash changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s FX effect on cash decreased by 3075.0% year-over-year, from $4K to -$119K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.